PULSE BIOSCIENCES INC
NASDAQ: PLSE (Pulse Biosciences, Inc)
Last update: 4 hours ago19.47
-0.53 (-2.65%)
Previous Close | 20.00 |
Open | 20.07 |
Volume | 144,001 |
Avg. Volume (3M) | 162,771 |
Market Cap | 1,197,730,048 |
Price / Sales | 60.23 |
Price / Book | 16.32 |
52 Weeks Range | |
Earnings Date | 26 Mar 2025 - 31 Mar 2025 |
Diluted EPS (TTM) | -0.820 |
Total Debt/Equity (MRQ) | 10.57% |
Current Ratio (MRQ) | 11.93 |
Operating Cash Flow (TTM) | -33.98 M |
Levered Free Cash Flow (TTM) | -18.81 M |
Return on Assets (TTM) | -38.15% |
Return on Equity (TTM) | -70.28% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
Medical Instruments & Supplies (Global) | Mixed | Mixed | |
Stock | Pulse Biosciences, Inc | Mixed | Mixed |
AIStockmoo Score
Analyst Consensus | NA |
Insider Activity | NA |
Price Volatility | -0.5 |
Technical Moving Averages | 2.5 |
Technical Oscillators | 0.5 |
Average | 0.83 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems. |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Investment Style | Small Growth |
% Held by Insiders | 80.81% |
% Held by Institutions | 9.90% |
Ownership
Name | Date | Shares Held |
---|---|---|
Griffin Asset Management, Inc. | 31 Dec 2024 | 237,547 |
Spotlight Asset Group, Inc. | 30 Jun 2024 | 40,290 |
Swiss National Bank | 30 Sep 2024 | 35,900 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |